| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1997;28:149-154.)
© 1997 American Heart Association, Inc.
Articles |
Hyperglycemia and the Vascular Effects of Cerebral Ischemia
the Departments of Surgery (Neurosurgery) (N.K., R.F.K., A.L.B), Pediatrics (A.L.B.), and Neurology (A.L.B.), University of Michigan (Ann Arbor).
Background and Purpose A well-demarcated infarct was observed after 4 hours of rat middle cerebral artery (MCA) occlusion with xylazine/ketamine but not pentobarbital or isoflurane anesthesia. This study examined whether this reflected vascular changes and, because xylazine induces hyperglycemia, whether glucose could cause similar vascular effects in cerebral ischemia.
Methods To examine the effects of anesthetics, rats were anesthetized for thread occlusion of the MCA with either xylazine/ketamine, pentobarbital, or isoflurane. To evaluate the effects of glycemia, acute hyperglycemia was induced by glucose injection. In both experiments, cerebral plasma volume (CPV) was determined using 3H-inulin after 4 hours of permanent occlusion, and cerebral blood flow was measured using [14C]iodoantipyrine following 2 hours of reperfusion after 2 or 4 hours of occlusion. The presence of cerebral hemorrhage after reperfusion was checked macroscopically and infarct volume with 2,3,5-triphenyltetrazolium staining.
Results The ischemic CPV was about 50% of the contralateral values with xylazine/ketamine but not with the other anesthetics. On reperfusion, ischemic cerebral blood flow with xylazine/ketamine anesthesia was approximately half that with pentobarbital. Use of xylazine/ketamine also resulted in more frequent hemorrhagic infarcts and a larger infarct volume. Induced hyperglycemia resulted in a CPV decrease in the ischemic compared with nonischemic tissue (4.0±0.5 versus 7.4±0.2 µL/g; P<.001). Hyperglycemia also caused poor reperfusion and increased the occurrence of hemorrhagic infarction (hyperglycemia, 15 of 20; normoglycemia, 1 of 11; P<.01).
Conclusions Hyperglycemia induces marked cerebrovascular changes, both during ischemia and during reperfusion, that may exacerbate tissue damage. Change in CPV during ischemia may be a useful clinical indicator in predicting poor hemodynamic recovery and occurrence of hemorrhagic infarction after reperfusion therapy.
Editorial Comment
Department of NeurologyUniversity of Miami School of MedicineMiami, Fla
This article has been cited by other articles:
 |
|
 |
|
  M. Yong and M. Kaste Dynamic of Hyperglycemia as a Predictor of Stroke Outcome in the ECASS-II Trial Stroke, October 1, 2008; 39(10): 2749 - 2755. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Qin, M. Karabiyikoglu, Y. Hua, R. Silbergleit, Y. He, R. F. Keep, and G. Xi Hyperbaric Oxygen-Induced Attenuation of Hemorrhagic Transformation After Experimental Focal Transient Cerebral Ischemia Stroke, April 1, 2007; 38(4): 1362 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Martin, S. Rojas, A. Chamorro, C. Falcon, N. Bargallo, and A. M. Planas Why Does Acute Hyperglycemia Worsen the Outcome of Transient Focal Cerebral Ischemia?: Role of Corticosteroids, Inflammation, and Protein O-Glycosylation Stroke, May 1, 2006; 37(5): 1288 - 1295. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Saha, J. Xia, S. K. Engle, Y.-F. Chen, W. Glaesner, and J. A. Jakubowski A Model of Controlled Acute Hyperglycemia in Rats: Effects of Insulin and Glucagon-Like Peptide-1 Analog J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1159 - 1164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Suarez Does Hyperglycemia Contribute to Secondary Injury in Subarachnoid Hemorrhage? Stroke, January 1, 2006; 37(1): 8 - 19. [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Saha, J. Xia, J. M. Grondin, S. K. Engle, and J. A. Jakubowski Acute Hyperglycemia Induced by Ketamine/Xylazine Anesthesia in Rats: Mechanisms and Implications for Preclinical Models Experimental Biology and Medicine, November 1, 2005; 230(10): 777 - 784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
NINDS ICH Workshop Participants Priorities for Clinical Research in Intracerebral Hemorrhage: Report From a National Institute of Neurological Disorders and Stroke Workshop Stroke, March 1, 2005; 36(3): e23 - e41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. N. Kernan, C. M. Viscoli, S. E. Inzucchi, L. M. Brass, D. M. Bravata, G. I. Shulman, and J. C. McVeety Prevalence of Abnormal Glucose Tolerance Following a Transient Ischemic Attack or Ischemic Stroke Arch Intern Med, January 24, 2005; 165(2): 227 - 233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Leigh, O. O. Zaidat, M. F. Suri, G. Lynch, S. Sundararajan, J. L. Sunshine, R. Tarr, W. Selman, D. M.D. Landis, and J. I. Suarez Predictors of Hyperacute Clinical Worsening in Ischemic Stroke Patients Receiving Thrombolytic Therapy Stroke, August 1, 2004; 35(8): 1903 - 1907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Lindsberg and R. O. Roine Hyperglycemia in Acute Stroke Stroke, February 1, 2004; 35(2): 363 - 364. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Deplanque, P. Gele, O. Petrault, I. Six, C. Furman, M. Bouly, S. Nion, B. Dupuis, D. Leys, J.-C. Fruchart, et al. Peroxisome Proliferator-Activated Receptor-{alpha} Activation as a Mechanism of Preventive Neuroprotection Induced by Chronic Fenofibrate Treatment J. Neurosci., July 16, 2003; 23(15): 6264 - 6271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Alvarez-Sabin, C. A. Molina, J. Montaner, J. F. Arenillas, R. Huertas, M. Ribo, A. Codina, and M. Quintana Effects of Admission Hyperglycemia on Stroke Outcome in Reperfused Tissue Plasminogen Activator-Treated Patients Stroke, May 1, 2003; 34(5): 1235 - 1240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bruno, S. R. Levine, M. R. Frankel, T. G. Brott, Y. Lin, B. C. Tilley, P. D. Lyden, J. P. Broderick, T. G. Kwiatkowski, and S. E. Fineberg Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial Neurology, September 10, 2002; 59(5): 669 - 674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B.-W. Song, H. V. Vinters, D. Wu, and W. M. Pardridge Enhanced Neuroprotective Effects of Basic Fibroblast Growth Factor in Regional Brain Ischemia after Conjugation to a Blood-Brain Barrier Delivery Vector J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 605 - 610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Kase, A. J. Furlan, L. R. Wechsler, R. T. Higashida, H. A. Rowley, R. G. Hart, G. F. Molinari, L. S. Frederick, H. C. Roberts, J. M. Gebel, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: The PROACT II trial Neurology, November 13, 2001; 57(9): 1603 - 1610. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Kent, V. M. Soukup, and R. H. Fabian Heterogeneity Affecting Outcome From Acute Stroke Therapy: Making Reperfusion Worse Stroke, October 1, 2001; 32(10): 2318 - 2327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, W. M. Pardridge, and R. F. Keep Neuroprotection in Transient Focal Brain Ischemia After Delayed Intravenous Administration of Brain-Derived Neurotrophic Factor Conjugated to a Blood-Brain Barrier Drug Targeting System Editorial Comment Stroke, June 1, 2001; 32(6): 1378 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Demchuk, L. B. Morgenstern, D. W. Krieger, T. Linda Chi, W. Hu, T. H. Wein, R. J. Hardy, J. C. Grotta, and A. M. Buchan Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator–Related Intracerebral Hemorrhage in Acute Ischemic Stroke Stroke, January 1, 1999; 30(1): 34 - 39. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bruno, J. Biller, H. P. Adams Jr., W. R. Clarke, R. F. Woolson, L. S. Williams, and M. D. Hansen Acute blood glucose level and outcome from ischemic stroke Neurology, January 1, 1999; 52(2): 280 - 280. [Abstract] [Full Text]
|
|